Helmsley Charitable Trust, New York, New York, USA.
Diabetes Technol Ther. 2020 Jun;22(6):440-443. doi: 10.1089/dia.2020.0219. Epub 2020 May 18.
Today, in the United States, we have a health care system that is designed to treat symptoms, not people-and to do so as cheaply as possible with the dual goals of minimizing costs and preventing hospital visits. We are failing on all fronts. We spend more money on health care per capita than our Organization for Economic Co-operation and Development (OECD) peers, and our outcomes are mediocre at best. Medicine is not personal, health care professionals often have their hands tied by payers, and geography has too much influence on the quality of care available. This has to end, especially since we have the technology to create a truly patient-focused, whole-person approach-one that treats physical and mental health equally and meets people where they are in every sense. Telemedicine can level the playing field and enable higher quality, decentralized care that-when needed-brings specialty care to the masses. Other technologies have an important role, too. For patients with insulin-dependent diabetes (type 1 diabetes), widespread uptake of continuous glucose monitors may be the game-changer we need right now that can facilitate telemedicine to remote places and remove health care disparities. Both health professionals and patients will win-and ultimately payers will, too.
如今，美国的医疗体系旨在对症治疗，而非针对患者进行治疗，其目标是尽可能以最低的成本来实现这一点，同时将成本最小化和防止住院作为双重目标。我们在各方面都失败了。我们在医疗保健方面的人均支出高于经济合作与发展组织 (OECD) 的同行，而我们的医疗效果充其量只能说是一般。医学不是人性化的，医疗保健专业人员经常受到付款人的束缚，而且地理位置对可获得的护理质量有太大的影响。这种情况必须结束，尤其是因为我们拥有创建真正以患者为中心、关注整体的技术，可以平等对待身心健康，并从各个方面满足人们的需求。远程医疗可以拉平竞争环境，实现更高质量、分散化的护理，在需要时将专业护理带给大众。其他技术也有重要作用。对于依赖胰岛素的糖尿病（1 型糖尿病）患者来说，广泛采用连续血糖监测器可能是我们目前需要的改变游戏规则的技术，可以促进远程医疗服务到偏远地区，并消除医疗保健差距。医疗保健专业人员和患者都将受益，最终支付者也将受益。
